RxDoctor Payments Data

Neil Wanee, MD

Family Medicine · Smithville, MSNPI 1730153586

Payments from drug & device makers

$715in general payments, 2019–2025

Across 25 payments — averaging $28.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$147
  • AstraZeneca$107
  • AbbVie$100
  • Indivior Inc.$91
  • Takeda Pharmaceuticals U.S.A., Inc.$86
  • Radius Health, Inc.$43
  • plus $141 from 6 others

What the payments were for

  • Food & beverage$64290%
  • Education$7310%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$715 in reported general payments places this provider in the 50th percentile of 971 family medicine providers in Mississippi.

See all family medicine providers in Mississippi

Medicare billing

Part B allowed, 2024
$3,390
Medicare patients
82
Services billed
224

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol119$146,561
MounjaroTirzepatide118$130,638
TrulicityDulaglutide71$87,591
JardianceEmpagliflozin64$76,698
OzempicSemaglutide67$75,661
LinzessLinaclotide83$65,928
Breztri AerosphereBudesonide/Glycopyr/Formoterol54$37,537
Trelegy ElliptaFluticasone/Umeclidin/Vilanter45$36,704
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl137$22,653
EliquisApixaban19$15,073
TrintellixVortioxetine Hydrobromide14$14,265
MyrbetriqMirabegron15$11,393
Gabapentin621$8,455
Breo ElliptaFluticasone/Vilanterol19$8,240
VyvanseLisdexamfetamine Dimesylate24$7,828

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$38$218,229189 claims
AstraZenecaFarxiga, Breztri Aerosphere$107$184,098173 claims
Novo NordiskOzempic$14$75,66167 claims
AbbVieLinzess, Synthroid$100$67,718106 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse$86$22,09338 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 971 family medicine providers in Mississippi.

Other family medicine in Smithville

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →